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INTRODUCTION
Neurocutaneous  disorders  are  genetically  determined  disorders  showing  both 
cutaneous  and  neurologic  involvement.  The  definition  includes  both  hereditary  and 
nonhereditary phenotypes but excludes acquired disorders.
Either  they  follow  the  established  Mendelian  modes  of  inheritance  or  they 
represent  lethal  mutations  surviving  by  mosaicism,  or  they  belong  to  the  group  of 
chromosomal disorders. 
Some clinicians  still  use  phacomatosis  to  categorize  particular  neurocutaneous 
diseases characterized by patchy lesions  involving the skin  and the nervous system. 
Unfortunately, this term has diminished rather than increased our understanding of these 
disorders because the group of phacomatoses has never been well defined. Today, this 
term should no longer be used for the classification of neurocutaneous diseases but may 
be applied, together with a specifying adjective, to some genetically determined diseases 
characterized  by  the  presence  of  multiple  nevi,  such  as  phacomatosis 
pigmentovascularis. 
REVIEW OF LITERATURE
Neurocutaneous  disorders  are  genetically  determined  disorders  showing  both 
cutaneous and neurologic involvement.
Either  they  follow  the  established  Mendalian  modes  of  inheritance,  or  they 
represent  lethal  mutations  surviving  by  mosaicism,  or  they  belong  to  the  group  of 
chromosomal  disorders.  Genetic  classification  will  confirm  the  well  established 
differences  between  Autosomal  dominant,  Autosomal  recessive  and  X-linked  gene 
expressions1.
The neurocutaneous syndromes can be classified as follows:
I. Autosomal Dominant Phenotypes:
1. Neurofibromatosis
2. Tuberous sclerosis complex
3. Waardenburg syndrome.
II. Autosomal recessive Phenotypes:
1. Xeroderma Pigmentosum
2.  Elejalde syndrome 
2. Oculo cutaneous albinism
III. X-linked male - lethal Phenotypes:
1. Incontinentia pigmenti.
2. Focal Dermal hypoplasia
IV. X-linked  – Non lethal Phenotypes:
1. Albinism – Deafness syndrome.
2. Menkes disease
V. Lethal autosomal mutations surviving by mosaicism:
1. Sturge Weber Klippel Trenaunay syndrome 
2. Schimmelpenning  syndrome 
3. Nevus comedonicus syndrome 
4. Proteus syndrome 
VI. Chromosomal disorders:
1. Klinefelter syndrome 
2. Trisomy 21
VII Phenotypes still unclassifiable according to formal genetics:
1. Johnston syndrome 
2. Satoyoshi syndrome 
THE NEUROFIBROMATOSIS
The neurofibromatosis comprise several distinct genetic disorders that lead to the 
formation of tumours surrounding nerves and a variety of pathological features.  The 
main two forms are:
1. Type -1 neurofibromatosis ( 85%) 
2. Type-2 neurofibromatosis ( 10%)2
NEUROFIBROMATOSIS - 1
Syn : VON RECKLINGHAUSEN NEUROFIBROMATOSIS 
Definition
NF -1 is an inherited neuroectodermal abnormality, characterised by the presence 
of six or more café-au-lait spots,  axillary freckles, multiple neurofibromas and Lisch 
nodules.
History  
Friedrich von Reckling Hausen in 1882 coined the term neurofibroma, who was 
the first to appreciate the neural character of the tumours. Virchow – reported positive 
family history. 
Etiology 
The mode of inheritance is autosomal dominant with 100% penetrance. Sporadic 
cases result from a high gene mutation rate.  The prevalance is 1 : 2500 – 3500. No 
gender or racial preferences. The gene for NF1 is located on chromosome 17. NF-1 gene 
has now been cloned and encodes a protein named neurofibromin, which is expressed 
predominantly  in  neurons,  Schwann  cells,  oligodendrocytes  and  leucocytes, 
keratinocytes  and  melanocytes.  Neurofibromin  shows  similarity  to  the  GTP  ase  – 
activating protein - and is capable of downregulating Ras activity.
Mast  cells  are  increased  in  neurofibromas  which  may  be  involved  in  the 
development and growth of these tumours by producing several growth factors such as 
histamine and tumour necrosis factor α ( TNF α ).
CLINICAL FEATURES
According to the National Institute of Health Consensus Development Conference 
Statement is based on 2 or more of the following criteria3.
1. Six  or  more  café-au-lait  macules  over  5mm  in  greatest  diameter  in 
prepubertal and over 15mm in post pubertal. 
2. Two or more neurofibromas of any type or one plexiform NF.
3. Freckling in the axillary or inguinal regions.
4. Optic glioma
5. Two or more Lisch nodules
6. Sphenoid  dysplasia  or  thinning  of  long  bone  cortex  with  or  without 
pseudoarthrosis
7. A first degree relative with NF-1 by the above criteria 
CUTANEOUS FEATURES - Café-au-lait Macules (CALM)
  Sharply defined light brown macules and  patches with smooth borders. Earliest 
to appear. Found all over the body except scalp, eyebrows, palms and soles. They vary 
in size.
Neurofibromas 
1. Cutaneous  neurofibroma  or  mollusca  fibrosa:  are  soft,  lilac,  pink,  sessile  or 
pedunculated tumours, mostly on the trunk and limbs, on gentle digital pressure, 
the  lesions  herniate  into  the  dermis  –  ‘button  holing’.  In  women  they  are 
prominent in the areola.
2. Plexiform neurofibromatosis :  Pathognomonic for NF-1 (occurs in <1%), Diffuse 
elongated fibroma along the course of a nerve, frequently involving the trigeminal 
or upper cervical nerves. They feel like a “bag of worms.” 
3. Elephantiasis  neurofibromatosa  is  associated  with  over  growth  of  the 
subcutaneous  tissue  and  of  the  skin,  produces  gross  disfigurement.  Dark 
pigmented patches over plexiform neurofibroma may be present.  If the tumour 
extends to the midline, it may indicate that the tumour involves the spinal cord. 
Neurofibromas may also involve viscera and blood vessels which may lead to 
constipation, bleeding  obstruction. Plexiform neurofibromas can be a precursor 
lesion for malignant peripheral nerve sheath tumour . 4
3. Freckling 
 Freckles are small,  tan brown macules that are 1–3mm in diameter,  diagnostic 
only when present in the axilla and groin. Crowe’s sign5 indicates axillary freckling. 
Palmar freckling6 can be a sign of neurofibromatosis.
Other Diagnostic Cutaneous Features7. 
Hypopigmentation  is  of  3  types  –  those  resembling  ash  leaf  macules,  small 
punctate  macules  and  local  areas  of  hypoplasia  that  can  appear  blue  red  (  Pseudo 
atrophic  macules  ).  Giant  pigmented  hairy  naevi,  cutis  verticis  gyrate,  angiomas, 
hypertrichosis, hyperpigmentation, and rarely piebaldism are associated with NF-1. The 
typical order in which clinical features appear are 1) Café-au-lait macules  2) Axillary 
freckling, 3) Lisch nodules, 4) neurofibromas ( according to NIH, National Institute of 
Health Criteria). Pruritus is a prominant but non specific cutaneous finding in 10% of 
cases due to increased mast cells in the skin.
NON CUTANEOUS FEATURES
I. Ocular
Lisch  nodules  -  Pigmented  melanocytic  iris  hamartomas  are  dome  shaped, 
translucent  brown spots,  bilateral  and asymptomatic,  most  common manifestation of 
NF-18, occurs in more than 90% of patients and does not occur in segmental type of NF. 
II. Neurological Manifestations
Occurs in 40% of patients. Most common is optic glioma. Optic glioma - is an 
Astrocytic  tumour  of  the optic  nerve occurs  in  15% of patients  with NF1,  80% are 
asymptomatic. The common features are epilepsy, cerebrovascular accident, headache, 
intellectual,  behavioural,  emotional  disturbances.  30% have  learning disabilities9 and 
poor school performance. The common intracranial tumours reported are astrocytomas 
and schwannomas.
III. Skeletal Manifestations
They are kyphoscoliosis (2%)10, sphenoid wing dysplasia often results in pulsating 
exophthalmos, congenital pseudoarthrosis (common in tibia or radius ) ( 0.5%). vertebral 
scalloping,  macrocephaly,  short  stature  (  growth  hormone  deficiency  is  reported  ). 
Thinning of cortex resulting in pathological fractures. 
IV. Oral Lesions
Occurs in (5 – 10%) of cases as Unilateral macroglossia, papillomatous tumours 
of palate, tongue, buccal mucous membranes and lips.
V. Endocrine abnormalities11
They  are  precocious  puberty,  acromegaly  /  gigantism,  Addison’s  disease, 
hyperparathyroidism, gynaecomastia and phaeochromocytoma. 
VI. Renal12
The common renal manifestation are renovascular hypertension13 due to (a) renal 
artery stenosis, b) phaeochromo cytoma, c) coarctation of aorta. Renal tubular defect 
resulting  in  osteomalacia.  Lower  urinary  tract  symptoms are  due  to  obstruction  and 
Wilms tumour. 
VII. Pulmonary Changes ( 10-20%) 
1. Firbrosing alveolitis, 2. Interstitial fibrosis
VIII. Gastro Intestinal ( 25%)14
Constipation  (dysfunction  of  colonic  musculature/colonic  NF).  Recurrent 
Haemorrhages  or  obstruction  or  intussuception,  frequently  occurs  in  stomach  and 
jejunum.
IX. Malignancies Associated with NF-1(3-5%)15
They  are  neurofibrosarcoma  (1.5-15%),  rhabdomyosarcoma,  retino  blastoma, 
malignant melanoma, Wilms tumour, several types of leukemia, malignant schwannoma 
with melanocytic differentiation. 
X. Other Association of NF-1
Gynaecomastia, Neurofibromatosis of the vulva16, Neurofibromatosis type I and 
Mycosis fungoides17 and associated with glioblastoma in a case of multiple sclerosis18, 
NF-1 and Mc Cune – Albright syndrome occuring in the same patient19, Juvenile Xantho 
granuloma,  late  onset  NF  in  a  liver  transplant  recipient20,.  Coexisting  Von 
Recklnighausens  neurofibromatosis  and  von  Hippel  –  lindau’s  disease21,  common 
variable  immuno  deficiency22 with  NF-1,  congenital  absence  of  the  inferior  rectus 
muscle23 and NF-1 with retinal vein occlusion24 in one case of NF-1 are reported.
RICCARDI’S  Classification System of NF25
NF Inheritance Main Clinical – Features
NF1 Autosomal 
dominant Gene 
17q 11.2 (AD)
Café-au-lait  spots  (CLS),  axillary  or  inguinal 
freckles,  Lischnodules,  NF, opticglioma, bone 
changes.
NF2 AD,  Gene 
22q12.2
Bilateral  vestibular  (acoustic)  schwannoma, 
multiple  CNS  Tumours  –  meningiomas, 
ependymomas,  spinal  astrocytomas,  cataracts, 
retinal hamatoma.
NF3 AD  (or) Features of NF1 and NF2 including some CLS, 
Sporadic freckling, NF, CNS or paraspinal tumours, no 
vestibular shawannoma or lisch nodules. 
NF4 Sporadic Atypical NF. Mostly occur as a variant of type 
II
NF5 Sporadic  or 
A.D  somatic 
mutation  of 
NF1  with  or 
without  germ 
cell mutation 
Segmental NF26 - NF-1 that is localized to one 
quadrant  /one side of  the body – arises  from 
post  zygotic  somatic  mutation  and  is  not 
heritable. It can occur as bilateral segmental NF 
with or without CLS
NF6 AD Multiple CLS, without neuro fibroma. It must 
occur in two generation to be diagnosed.
NF7 Sporadic Adult onset cutaneous NF with onset at end of 
3rd decade  or  later.  Lisch  nodules  are  absent. 
NF also appears after immunosuppresion22. 
NF8 Case which are definitely NF but do not fit into 
any of the other categories. 
Histopathology27
The histologic spectrum of neuro fibromas in NF-1 is as follows: 
Types
I. Extra neural Variants:
(i) Cutaneous  extraneural  variant  (  Extra  neural  sporadic  cutaneous 
neurofibromas ESCN )
(ii) Deep, diffuse ( extraneural ) variants.
II. Intraneural Variants:
(i) cutaneous or deep circumscribed variant
(ii) Plexiform variants. 
Histological Types
1.  Extra neural sporadic cutaneous neurofibromas ( ESCN )
These  tumours  are  faintly  eosinophilic,  and  are  circumscribed  but  not 
encapsulated showing thin spindle cells with elongated, wavy nuclei which are 
regularly spaced  among thin wavy collagenous strands. It can be homogenous 
( closely packed ) or loosely spaced in a clear matrix. There are large number of 
mast cells and nerve fibres. 
2. Extraneural deep diffuse variant 
The  matrix  is  either  delicately  fibrous  and  faintly  acidophilic  or  more 
coarsely, fibrous and brightly acidophilic.  Nerves within the lesion usually are 
small,  internally  symmetrical  and  hypercellular  and  the  perineuria  are 
hyperplastic. 
3. Deep circumscribed (intra neural) variant and plexiform variant 
Here,  the  axial  bundles  of  symmetrically  arranged  nerve  fibres,  are 
remnants  of  the  axial  bundle  of  the  nerve  of  origin.  The  schwann  cells  are 
hyperplastic  and  tightly  placed.  Ultrastructurally,  the  cells  of  neurofibroma 
resemble those of perineural cells/schwann cells as well as fibroblasts.  Special 
stains used are Silver stain and Bodian stain. Immuno histochemical markers that 
are  used  are  S-100  protein  (+),  CD57  antigen  (leu-7),  Myelin  basic  protein 
(MBP), NSE ( Neuron – Specific enolase), GFAP ( Glial fibrillary acidic protein 
and EMA (Epithelial membrane antigen).
Variants
There are 3 variants. Schwann cells with enclosed axons, are an integral part of 
NF. Perineural variants are rather, uniformly & densely fibrous, and their cells are bi or 
tri  polar  with  rigid  processes.  Endoneurial  variants  are  characterised  by  thickened 
perineurium  with  few  axial  bundles  and  isolated  cells,  in  an  expanded,  mucinous 
endoneurial component. In Schwannaian variants, thickened perineurium with few axial 
bundles and spindle cells are spaced among asymmetrical collagen bundles.
Histopathology of 
Café-au-lait macules
Shows a total increase in the amount of melanin in melanocytes and keratinocytes 
by  silver  stain.  Melanocyte  count  is  higher  than  in  normal  individuals.  Giant 
melanosome,  ‘Macro  melanosomes’  are  present.  (Autophagosome  merged  with  a 
secondary lysosome)
Lisch nodules
Consists of condensation of  spindle  cells  on the anterior  iris  surface.  Immuno 
histochemically positive for S100 and vimentin. 
Freckles
Hyperpigmented  basal  layer.  No  elongation  of  rete  ridges.  No  increase  in 
melanocyte concentration.
TUBEROUS  SCLEROSIS  COMPLEX (TSC)
Synonyms :  EPILOIA, BOURNEVILLE’S DISEASE
Definition
Tuberous sclerosis complex (TSC) is an autosomal dominant disease attributable 
to mutations in one of the two different genes. Lesions are characterized by systemic 
hamartomas involving mostly the skin, nervous system, heart, eyes and kidneys.
History
Virchow (1860) :Was  the  first  person  to  describe  the  brain  lesions  in  TS. 
Bournville (1880) :Showed relation between the skin  and brain lesions Vogt (1908): 
Described the classic triad of  Adenoma sebaceum, epilepsy & mental retardation. Van 
der Hoeve: Introduced the term phakomatosis Phakos is the Greek word means lentil, 
flatplate or spot.
Epidemiology 
Occurs in 3-10 / 100000. All races and both sexes are affected and has world wide 
distribution.
Etiology
Inheritance is by: 1. Single autosomal dominant gene with variable expression of 
40%, 2. Sporadic cases due to new mutations. (60%).
2 specific genes are involved, namely :
I. TSC  1  (  Chromosome  9q34),  it  encodes  for  a  protein  (‘HAMARTIN’) 28.  It 
accounts for 30-50% of all familial cases.
II. TSC 2 ( Chromosome 16p13) : It encodes for a protein “TUBERIN”28 which in 
homologous  to  GTP activating  protein  Rap1  is  involved  in  regulation  of  cell 
proliferation & differentiation (similar to Ras oncogene in neurofibroma). When 
tumour  suppressor  role  is  lost,  tumour  formation  occurs.  Also,  loss  of 
heterozygosity in TSC 2 gene leads to tumour production. 
Clinically 
 The  most  commonly  observed  manifestations  are  of  skin,  CNS  followed  by 
ocular, cardiac and renal. 
In  1998,  the  diagnostic  criteria  from  the  consensus  report  of  the  National 
Tuberous Sclerosis Association were modified and divided into 2 groups:  major and 
minor criteria as followed.
Revised Diagnostic Criteria for Tuberous Sclerosis Complex29: 
Major features:
 Facial angiofibromas or forehead plaque 
 Nontraumatic ungula or periungual fibroma 
 Hypomelanotic macules ( 3 or more ) 
 Shagreen patch (connective tissue nevus) 
 Multiple retinal nodular hamartomas 
 Cortical tuber 
 Subependymal nodule 
 Subependymal giant cell astrocytoma 
 Cardiac rhabdomyoma, single or multiple 
 Lymphangiomyomatosis 
 Renal angiomyolipoma
Minor features:
 Multiple randomly distributed pits in dental enamel
 Hamartomatous rectal polyps
 Bone cysts
 Cerebral white matter radial migration lines 
 Gingival fibromas 
 Nonrenal hamartoma
 Retinal achromic patch 
 “Confetti” skin lesions 
 Multiple renal cysts.
Definite TSC : Either 2 major features or 1 major feature plus 2 minor  features.
Probable  TSC: 1 major feature and 1 minor feature
Possible TSC: Either 1 major feature or 2 or more minor features.
CLINICAL FEATURES : Cutaneous – Seen in 60 to 70%
1. Facial angiofibroma (80 to 90%) starts at around 3-10 years. 80 to 90% starts at 
around 3 to 10 years. Firm, discrete, red brown, telangiectatic papules, 1 to 10 mm 
in size, extending from nasolabial furrows to the cheeks and chin. They are rarely 
present in the forehead and scalp. Unusual types - Cauliflower like, segmental 
forms with unilateral distribution30. Rarely solitary angiofibroma is reported as an 
abortive  form  of  TSC.  Multiple  facial  angiofibroma  like  lesions  have  been 
observed in multiple endocrine neoplasms. (Multiple Endocrine Neoplasia Type1)
2. Ash leaf macules (85%). They are ovoid or lance ovate shaped macules present at 
birth (earliest marker) 31,32.Also seen in a confetti like or segmental distribution 
and easily  detectable  by wood’s lamp.  They are commonly  seen in  trunk and 
limbs.
3. Shagreen  patch  (25  to  50%)  commonly  located  in  lumbosacral  region33, 
irregularly thickened ,  slightly elevated, skin colored plaque with a “pig skin’, 
‘elephant hide’,  or  ‘orange peel appearance.
4. Periungual fibromas ( Koenen’s tumours )34 15 to 20% smooth, firm, flesh colored 
excrescences emerging from the nail  folds.  It  appears after  or  around puberty. 
These fibromas lead to thinning  and destruction of the nail plate. They are 5 to 
10mm in size. 
Other cutaneous lesions
Gingival, palatal & lip fibromas, firm fibromatous plaques over the fore head / 
scalp,  soft  fibromas in neck & axilla ( 5.7%), port wine stain, café-au-lait  macules, 
poliosis.  Enamel pits ( common in adults) which are conical  and cylindrical shaped, 
80-500 microns in size is a constant and pathognomic sign.
Systemic Manifestation : CNS
Seizures35 – seen in all cases with mental retardation. Earliest and most frequent 
complaint in TSC. They may be temporal lobe epilepsy, persistent infantile spasm like 
seizures (21.2%), tonic clonic seizures (37.1%), intractable seizures. Mental deficiency 
(60  to  70%)  with  or  without  behavioural  disorders,  psychiatric  manifestations  like 
schizophrenia  and  depression  can  be  seen.  Tumours  :  Sub  ependymal  giant  cell 
astrocytoma,  cortical  tubers,  sub  ependymal  nodules.  Forehead  plaque  may  be  a 
cutaneous marker of CNS involvement in TSC36.
II. Renal manifestations
The  common  renal  manifestations  reported  are  renal  angiomyolipoma37,  renal 
artery stenosis,  aneurysmal dilatation of internal carotid artery and renal arteries and 
polycystic  kindneys (12%).  Hypertension  in  children with  TSC can be due  to  renal 
parenchymal  lesions  (cysts  and  angiomyolipomas).  Other  rare  reported  features  are 
unilateral  anglomyolipoma  and  renal  failure.  Malignant  epitheloid  renal 
angiomyolipoma in a patient with TSC is reported. In some cases, this is related to a 
contiguous gene syndrome because mutations span both the TSC2 gene and the adjacent 
polycystic kidney disease gene (PKD).
III. Pulmonary Manifestation38
Pulmonary  lymphangioleiomyomatosis,  proliferation of  smooth  muscle  cells  is 
common in women. Micronodular multifocal pneumocyte hyperplasia, lung cysts and 
recurrent  intra  pleural  cysts  are  common.  Acute  pulmonary  embolism from cardiac 
tumours  are  reported.  Others  are  micronodular  pneumocyte  hyperplasia  of  the  lung, 
spontaneous pneumothorax, chylothrox due to underlying pulmonary disease.
IV. Ocular Manifestation 50%
Occur  in  50%.  Retinal  phacomas  are  seen.  Pigmentary  and  other  retinal 
abnormalities can occur. Symptoms are rare.  There may be scotomas or  amaurosis. 
Hypopigmented spots in the iris also occur.
V. Cardiac Manifestation
Benign  rhabdomyomas  of  the  heart  are  common and  may  be  associated  with 
conduction defects. 80% of all children presenting with Rhabdomyoma have TSC. Fetal 
cardiac rhabdomyomatosis is a prenatal marker for the detection of latent TSC39. 
VI. Other disorders associated with TSC
Benign tumours have been found in the liver, thyroid, testes and gastrointestinal 
tract. Pituitary –adrenal dysfunction, thyroid disorders and premature puberty, primary 
localized gigantism and diffuse cutaneous reticulohistiocytosis have been reported. 
HISTOPATHOLOGY27
 Angiofibroma  :  hyperplastic  blood  vessels  with  increased  dermal  collagen 
( synthesis & turnover ), atrophic sebaceous glands and immature hair follicles. 
 Shagreen  patch:  2  types  (  histopathological  ).  Sclerotic  mass  of  very  broad 
collagen bundles in an interwoven pattern (common), Uniform mass of collagen 
with fibroblasts. 
 Periungual fibromas: Distal part: Loose collagen & many blood vessels. Proximal 
part: Dense collagen bundles with few capillaries. 
 Ash leaf macule: normal number of melanocytes, defective melaninisation due to 
decreased tyrosinase activity. 
XERODERMA PIGMENTOSUM
Definition:
Xeroderma Pigmentosum  is a rare autosomal recessive disease characterized by 
photosensitivity, pigmentary changes, premature skin ageing, neoplasia and abnormal 
DNA repair. Some patients with XP also have neurological complications.
History:
The initial report of this disorder was made by Hebra and Kaposi in 187440 and 
the  term Xeroderma  pigmentosum,  meaning  pigmented  dry  skin,  was  introduced  in 
1882.  Cleaver  (1968)41 reported  defective  DNA  excision  repair  in  UV  irradiated 
fibroblasts in patients with XP.
Epidemiology:
XP  is  distributed  worldwide,  frequency  being  1:250,000,  inherited  autosomal 
recessively with equal sex ratio. 
Aetiology and Pathogenesis :
There  are  at  least  eight  different  subtypes  that  are  recognized,  designated  as 
complementation groups A-G and XP variant. 80% of patients with XP show a defect in 
the initiation of DNA excision repair of UV photoproducts. Repair replication is reduced 
in all cell types.
Nucleotide excision repair42. This process, whereby damaged DNA is removed 
and replaced with new DNA using the intact strand as a template, involves the products 
of some 30 genes43.
The names of the XP genes have superseded those of the corresponding excision 
repair cross-complementing genes. The initial step in the process involves recognition of 
the damaged DNA by the XP-C with its partner HR23B. This results in the recruitment 
of  the  dual  function  transcription  factor  TFIIH,  composed  of  at  least  six  subunits 
including XP-B and XP-D proteins, which have helicase activity. These helicases open 
out the structure at the damaged site. XP-A verifying the positions of other proteins on 
damaged structure. XP-G and XP-F cut DNA on either side of damage. New DNA is 
joined with old DNA by ligase.  XP-E binds specifically to UV irradiated DNA and 
assists in the early recognition.
Drug and Chemical Hypersensitivity44 :
A number of DNA damaging agents other than UV radiation have been found to 
yield hypersensitive responses with XP cells.  These agents include drugs (psoralens, 
chlorpromazine), cancer chemotherapeutic agents ( cisplatin, carmustine), and chemical 
carcinogens ( benzopyrene derivatives). These agents induce DNA damage whose repair 
involves portions of the DNA repair pathways that are defective in XP.
XP  Variant45 :
20% of  XP patients called XP variants, have normal NER but have a defect in an 
alternative repair process,  known as post  replication or  daughter – strand repair.  XP 
variants  have  a  defect  that  manifests  as  a  reduced  molecular  weight  of  newly 
synthesized DNA in UV-irradiated cells. 
The majority of patients are in group C, and they show no neurological disease. 
Patients in group A tend to develop neurological disease before the age of 7 years, group 
D tend to develop neurological damage after 7 years46. 
Skin photosensitivity :
Some cases of the typical form show a papular and vesicular reaction, mainly to 
light in the 290 – 320nm range47. The minimal erythema dose is lower than normal at 
most wavelengths. 
XP and Neoplasia:
Cultured  dermal  fibroblasts  from  XP  patients  exhibit  increased  UV-induced 
mutagenesis. Neoplasms in sun exposed areas of XP patients are due to the result of UV 
induced mutations. Mutations bearing a UV signature in the p53 and PTCH genes48. UV 
exposure also triggers a complex series of signal transduction pathways that result in 
immunosuppression of the skin, which may be an important factor49. 
CLINICAL FEATURES: 
Cutaneous Features50:
The skin is normal at birth. Onset is between 6 months and 3rd year of life. Rate of 
progression  is  unpredictable.  Freckling  and  increasing  dryness  on  light  –exposed 
surfaces are usually the earliest manifestations; they may follow and acute sunburn or 
more persistent erythema. The freckles appear first on the face and hands and later on 
other  exposed  parts.  Telangiectasias  and  small  angiomas  appear.  Small,  round  or 
irregular,  white,  atrophic spots are soon added.  Some follow crusted vesiculobullous 
lesions.  Superficial  ulcers,  healing  with  difficulty,  leave  disfiguring  scars,  and 
contractures may produce ectropion. 
Benign tumours like keratoacanthomas and actinic keratoses, malignant tumours 
like  basal  cell  carcinoma,  squamous  cell  carcinoma.  melanomas,  angiosarcoma  and 
fibrosarcoma may occur. 
Occular lesions:
Eyes  are  affected  in  80% of  XP  patients.  Photophobia  and  conjunctivitis  are 
common  early  symptoms.  Ectropion,  destruction  of  the  lower  lids,  symblepharon, 
ulceration, pigmented macules, vascular pterygium, corneal opacities and epitheliomas 
of the lids, conjunctiva or cornea may develop.
Neurological Complications:
Neurological abnormalities occur in approximately 20% of XP patients, with one 
or more of the following: mental retardation, areflexia or hyporeflexia, spasticity, ataxia, 
sensorineural  deafness,  seizures  dysphasia  and  abnormal  electroencephalographic 
findings.  DNA repair mechanisms are essential for maintaining the normal function of 
neurons, and progressive damage, perhaps caused by ingested or endogenous chemicals, 
might cause premature death of susceptible neurons. 
The most severe form, known as the De Sanctis-Cacchione syndrome51, involves 
the cutaneous and ocular manifestations of classic XP with additional neurologic and 
somatic  abnormalities,  including microcephaly,  progressive mental  deterioration,  low 
intelligence,  hyporeflexia  or  areflexia,  choreoathetosis,  ataxia,  spasticity,  Achilles 
tendon shortening leading to eventual  quadraparesis,  dwarfism,  and immature sexual 
development. 
Associations are short stature, Cockayne’s Syndrome,52  SLE53   and Pilomatricoma.54
HISTOPATHOLOGY
 Resembles senile skin. Epidermis is thinned and flattened and the dermal collagen 
shows basophilic degeneration. Irregular proliferation of rete pegs, heavily laden with 
pigment,  is  a  distinctive  feature.  Electron  microscopic  studies55 show  shrinkage  of 
kerationocytes  and  their  nuclei.  Melanocytes  are  also  abnormal,  with  polymorphic 
melanosomes, and there may be giant pigment granules in melanocytes or keratinocytes. 
The dermal fibroblasts appear to behave like macrophages. In hypopigmented macules 
the melanocytes are scanty, but Langerhans cells are numerous56.  
WAARDENBURG  SYNDROME
Definition
It  is  an  autosomal  dominant  neural  crest  cell  disorder,  phenotypically 
characterized by hearing impairment and disturbance in pigmentation. It has a variable 
penetrance of its constituent anomalies57. 
Type 1 : Classical form, with dystopia canthorum occurs due to 
mutation  of the PAX-3 gene on chromosome 2q35. Sensory neural 
deafness is  due to lack of melonocytes in inner  ear  and defective 
development of striae vascularis. 
Type II : Similar features but, lacks dystopia canthorum. 
Mutation in MITF gene.
Tpye III : (Klein–Waardenburg syndrome) associated with limb 
abnormalities  and  dystopia  canthorum,  due  to  mutation  of  the 
PAX358 gene on chromosome 2q35.
Type IV      : Caused by mutations in the genes for endothelin-359, endothelin –B 
and SOX 10. Variant – associated with Hirschsprung’s disease also 
called as Shah – Waardenberg syndrome60.
Ultra structurally, the amelanotic skin shows absence of melanocytes61. In the pigmented 
areas, there are abnormalities of the melanocytes and melanosomes.
CLINICAL FEATURES62
The abnormalities are present at birth. The most constant features of the syndrome 
is lateral displacement of the inner canthi and the lacrimal puncta, prominent nasal root, 
and medial eyebrows, congenital deafness and heterochromic irides. White forelock with 
premature graying of hair. Some cases show piebaldism. 
NAEVUS COMEDONICUS 
Synonyms : COMEDO NAEVUS
Definition :   First  described  in  1895.  The  comedo  naevus  is  a  linear  lesion 
comprising numerous keratin filled pits sometimes with acneiform pustules. 
AETIOLOGY 
It is an uncommon developmental defect of the pilosebaceous apparatus, which 
can be associated with various developmental abnormalities of the skeletal system, the 
CNS,  skin  and  eye.  This  reflects  mosaicism  for  a  variety  of  mutations  that  can 
predispose to acne. The lesion occurring in the palms, soles and glans penis could arise 
from an ectopic pilosebaceous unit or eccrine duct. 
HISTOPATHOLOGY
Deep  and  wide  invaginations  of  epidermis  filled  with  concentric  lamellae  of 
keratin. Rudimentary hair follicles, sebaceous glands and trichilemmal cysts can be seen 
in such lesion. Interfollicular changes typical of common verrucous epidermal nevi is 
sometimes seen. 
Types:  There are two other autosomal disorders featuring widespread comedones. 
1. Familial diffuse comedones :  Commonly called as ‘nevus comedonicus’. The 
comedo-like lesions appear in a diffuse bilateral distribution.
2. Familial dyskeratotic Comedones :  Here comedones are less extensive and 
demonstrate dyskeratosis histologically.
CLINICAL FEATURES - Cutaneous 
Comedo naevi  comprises  of  groups  of  pits  filled  with  black  keratinous  plugs 
resembling black heads. There may be one or several lesions may be very extensive 
common sites – face, neck, trunk and upper arm, palms, soles and glans penis may be 
occasionally involved. Scalp is rearely affected. Lesions are rarely present at birth but 
more often appear during childhood or adolescence. 
Associations  :  Trichilemmal63 cyst,  benign  and  malignant  tumours,  ipsilateral 
cataract,  skeletal  malformations,  extensive naevus  flammeus,  transverse  myelitis  and 
perforating elastoma. 
Complications  :   Chronic  inflammation,  suppurations  fistula  formation  and 
hypertrophic scarring ( nevus acneformis )
EPIDERMAL NAEVUS SYNDROME
Synonyms :  Feurstein  –  Mims  syndrome;  Schimmelpenning’s  syndrome; 
Organoid Naevus syndrome; Jadassohn’s naevus phakomatosis.
Definition :  The epidermal nevus syndrome is a disease complex of epidermal 
nevi and developmental abnormalities of different organ systems, like skeletal,  CNS, 
ocular, dental and cardiovascular system as well can be involved.
Etiology :  It  is likely that the syndrome reflects genetic mosaicism for one or 
more lethal autosomal dominant genes. 
I. Cutaneous Associations.
The  verrucous  epidermal  naevi  and  sebaceous  naevi  are  variants  of  a  single 
pathological process, differing in the site of lesion. Other cutaneous abnormalities are 
naevi flammei, hypochromic naevi, café-au-lait macules, congenital melonocytic naevi 
and spitz naevi. Naevi can involve mucosae of the mouth, anus or genitalia. Naevus 
sebaceous syndrome association in 3 patients is reported64. 
II. Dental Anomalies
Enamel hypoplasia, hypodontia, malformations of the teeth, maxillary giant cell 
granuloma.
III. Skeletal Abnormalities
Kyphosis,  scoliosis,  cystic  and lytic  changes65,  hypertrophy and atrophy,  short 
limbs, syndactyly, vitamin – D resistant rickets66 with bone and muscle weakness. 
IV. Neurological abnormalities67
Occurs in 50% of patients. More frequent in patients with sebaceous naevi on the 
head  and neck.  50% of  patients  have  seizures  especially  infantile  spasms.  50% has 
mental retardation, 20% have  spastic hemiparesis and spastic tetraparesis. 
CNS structural abnormalities 
Commonest  :  Ipsilateral  gyral  malformations,  complete  or  partial 
hemimegalencephaly,  vascular  malformations,  hemiatrophy,  posterior  cranial  fossa 
anomaly,  lateral  ventricle  enlargement,  porencephaly,  agenesis  of  corpus  callosum, 
hamartoma and cranial nerve palsies. 
Eye : 
 35-70% are involved. Commonest feature is eye lid involvement of epidermal 
naevus causing trichiasis or difficulty in lid closure. Others are Coloboma of eyelid, iris 
and retina, retinal dysplasia, conjuctival lipodermoids, choristomas68, cortical blindness, 
micro / macrophthalmia, anophthalmia, corneal opacities and cataracts. 
Other associated anomalies  
Carcinomas : Benign and malignant transformations, systemic malignancies like 
nephroblastoma,  salivary  gland  carcinoma,  carcinoma  of  stomach  and  esophagus, 
carcinoma of breast, astrocytoma, glioma, mandibular ameloblastoma, transitional cell 
carcinoma of the bladder, rhabdomyosarcoma of the bladder and intrathoracic teratoma 
are reported.
GIANT  CONGENITAL MELANOCYTIC NAEVUS
Neurocutaneous melanosis is  defined by the presence of  neurologic  symptoms 
and increased  number  of  melanocytes  in  central  nervous  system combined  with  the 
presence of large cutaneous naevus. A giant congenital nevus is a nevus greater than 
20cm. The most common location is on the back, head, neck and extremities.  Malignant 
melanoma (4.5% - 8%) can arise from a giant congenital naevus within first decade of 
life. 
• Symptoms : Headache, vomiting, failure to thrive, weakness, gait abnormalities, 
bowel and bladder dysfunction. The signs and symptoms manifest within first 3 
years of life. Occur in 12% cases with neurocutaneous melanosis. The signs are 
hydrocephalus, macrocephaly,  increasing head circumference, bulging fontenelle, 
seizures and developmental delay. 
Associated Findings with Giant Congenital Melanocytic Naevus 
Local Changes – Loss of subcutanesous fat and limb hypoplosia. Malignancies – 
Malignant  melanoma,  liposarcoma,  rhabdomyosarcoma,  primitiveneuroectodermal 
tumours,  mixed  malignant  neoplasm.  Malformations  –  Vascular  malformations, 
supernumerary nipples, ear deformities, preauricular appendages, cryptorchidism, club 
Foot.
Large congential naevi are reported more frequently with neuro fibromatosis type 
I69. Patients with ‘satellite’ melanocytic naevi are at a greater risk for the development of 
manifestations than patients without satellite lesions. 
STURGE – WEBER SYNDROME ( SWS)
Synonyms : Encephalotrigeminal angiomatosis.
Definition :   SWS is  a  rare,  sporadic,  neurocutaneous  disorder  consisting of 
facial  capillary  vascular  malformations  or  port  wine  stain  in  a   trigeminal  nerve 
distribution in association with ipsilateral neurologic and ocular abnormalities.
Incidence :   1 in 50000; equal sex incidence
Cutaneous Findings
Erythematous,  blanching,  segmental  homogenous patch that  is  restricted to the 
midline ( although can be bilateral ) is noted on the face shortly after birth. This evolves 
into characteristic port wine stain, with or without nodular lesions. 
Distribution :  One half of forehead, ipsilateral eyebrow, upper eye lid, nasal sidewall 
(opthalminc branch of trigeminal nerve ) must be affected to diagnose SWS. Port wine 
stain can be bilateral also. However, port wine stains over maxillary and mandibular 
branches of V nerve are not at risk of SWS. 52% have additional port wine stain else 
where.
Neurologic Manifestations 
Seizures,  developmental  delay,  contralateral  hemiplegia,  mental  retardation, 
homonymous hemianopia and sporadic hemiplegic migraine. Seizures (80%) present as 
infantile  spasms,  generalized  tonic  clonic  or  focal  seizures.  Classically  seizures  are 
difficult to control with medications. 
Ocular manifestations.
Occurs ipsilateral to the port wine stain; Glaucoma occurs in 50%, cases. It starts 
before 1 year of age. Retinal vascular anomalies in the posterior pole are seen – “Tomato 
catsup”  fundus.  Visual  field  impairment  and  buphthalmos  also  occur.   Choroidal 
angiomas push the retina forward producing a refractive abnormality termed hyperopia. 
Etiology: Defect  occur  during  embryogenesis  (  5-8th week  )  of  the 
mesoectodermal tissue. 
Unusual Associations of SWS.  Phakomatosis pigmentovascularis,  Klippel – Trenauny 
– weber syndrome70 and naevus of ota71. 
ELEJALDE  SYNDROME
Neuroectodermal melanolysosomal disease72. Autosomal recessive by inheritance. 
It should be distinguished from Chediak Higashi syndrome and Griscelli syndrome73.
Characteristic Features are:
• Bronze skin,  silvery hair,  severe CNS dysfunction,  mental  retardation,   severe 
hypotonia and seizures 
• Hair shaft examination shows coarse irregular pigment clumps within hair shaft.
OCULOCUTANEOUS  ALBINISM
It is an autosomal recessive disorder characterized by partial or complete failure 
to  produce  melanin  in  the  skin  and  the  eyes.  Melanocytes  are  present  in  normal 
distribution but fail to synthesize melanin adequately. There are 11 subtypes. Among 
these tyrosinase negative, tyrosinase positive and yellow mutant types are significant. 
Cutaneous features  : Absence of pigment in the skin and hair74. They are prone to 
develop actinic keratosis, squamous cell carcinoma, melanoma in the sun exposed skin 
at an early age.
Ocular features : Nystagmus, photophobia, strabismus, reduced visual acuity
ADAMS  OLIVER SYNDROME
It is an autosomal dominant disorder characterized by congenital midline scalp 
defects and asymmetrical distal limb reduction anomalies. 
Skin lesions are solitary or  multiple  bald scars,  near  the vertex.  Dilated scalp 
veins76 are  frequently  associated.  Intellect  is  normal.  Hypoplastic  or  absent  distal 
phalanges  are  the  most  common  limb  anomalies77.  Lower   limb  more  commonly 
affected. Congenital heart disease affects about 8% of cases. Persistent cutis marmorata78 
reported in 12% of cases. 
AIM OF THE STUDY
1. To study the incidence of Neurocutaneous disorders in the outpatients attending 
the Department of Dermatology in Government General Hospital, Chennai, from 
July 2006 to September 2008.
2. To determine the age and sexwise distribution of Neurocutaneous disorders. 
3. To study the clinical morphology and distribution of lesions. 
4. To correlate the morphological lesions with the histopathological freatures.
5. To evaluate incidence of associated systemic abnormalities. 
6. To determine the involvement in other family members. 
MATERIALS  AND METHODS
The  study  was  conducted  at  the  Department  of  Dermatology   Government 
General  Hospital,  Chennai  for  a period of 24 months,  from July 2006 to September 
2008. Patients were selected among those attending the outpatient department with signs 
and symptoms pertaining to neurocutaneous syndromes.
Preliminary  informations like age, sex, educational qualification, present and past 
illness,  family  history  along  with  consanguity  were  elicited.  A  detailed  systemic 
examination was done, particularly central nervous system. 
Dermatological examination consisted of thorough screening of patients to detect 
the cutaneous markers for neurocutaneous disorders. Ophthalmic examination, Ear and 
dental examinations were also carried out in relevant cases.
Apart  from the  routine investigations  like hemogram,  renal  and liver  function 
tests, X-rays, ECG, Echo, EEG, CT scan and MRI were done in appropriate cases. Skin 
biopsies  were  carried  out  in  willing  patients  who  included  23  patients  with 
neurofibromatosis,  5  cases  of  tuberous  sclerosis,  one  case  of  naevus  comedonicus, 
xeroderma pigmentosum and Adams Oliver  syndrome,  Giant  congenital  melanocytic 
naevus each.
Whenever  systemic  abnormalities  were  detected  /  suspected  the  patients  were 
referred  to  appropriate  speciality  departments  like  the  department  of  cardiology, 
ophthalmology, orthopedics and neurology for further investigations and management. 
All the patients were followed to detect the onset of other neurological and systemic 
manifestations. 
The data thus obtained was compiled tabulated and statistically summarized.
OBSERVATION AND  RESULTS
INCIDENCE:
Out of the total 30056 new patients attending skin OP at GGH during the period 
between July  2006 to  September  2008,  the number  of  patients  with neurocutaneous 
disorders were 109. Incidence of neurocutaneous disorders was 0.3%. Out of 109, the 
following diseases were found to occur in the order of frequency.
1. Neurofibromatosis - 75 68.8%
2. Tuberous sclerosis complex - 20 18.3%
3. Xeroderma pigmentosum - 3  2.7%
4. Giant congenital melanocytic naevus - 2  1.8%
5. Epidermal naevus syndrome - 2  1.8%
6. Waardenburg syndrome - 2  1.8%
7. Sturge weber syndrome - 1  0.9%
8. Naevus Comedonicus - 1  0.9%
9. Elejalde syndrome - 1  0.9%
10. Oculo Cutaneous albinism. - 1 0.9%
11 Adams Oliver Syndrome - 1 0.9%
NEUROFIBROMATOSIS (NF)
Of the 75 case of NF, 68(90.6%) cases were of type-1, 4 cases (53.3%) were of 
type-V and 2 cases (2.6%) were type VI, and 1 case of  type-II (1.3%). Age and sex 
distribution : The age group of patients with neurofibroma ranged from 6 to 60 years 
with the mean age 33 years.
TABLE-1
The Age And Sex Distribution Among Patients   With Nf ( N=75)
Age No. of Cases M F
0 – 10 yrs 3 2 1
11 – 20 yrs 23 14 12
21 – 30 yrs 22 9 10
31 – 40 yrs 14 9 5
41 – 50 yrs 7 6 1
51 – 60 yrs 6 2 4
Total 75 42 33
Highest age incidence was between 11 – 20 years.
Family History : There was history of consanguinity in 14 cases (18.6%)
The  neurofibromatosis  were  encountered  among  the  family  members  in  19  cases 
(25.3%). Fathers were affected in 9 cases, Mother in 3 cases, Brother in 4 cases, Sister in 
2 cases and daughter in 3 cases. More than one family member in 2 cases.
1) General examination : Short stature in one case. Other cases were normal. 
2) Systemic examination :  Bony abnormalities noted in 6 patients(8%) in the form of 
kyphoscoliosis, facial asymmetry and local gigangitism, each comprising of 2 cases 
respectively (2.6%).
3) Central  nervous  system  examination  :  4  patients  affected  with  seizures,  3  with 
learning difficulties, 2 cases with delayed milestones and MR respectively.
4) Ophthalmic examination : 61(81.3%) patients were found to have lisch nodules in  
the eye, all of them bilaterally.
TABLE-2
Systemic manifestations observed in patients with neurofibromatosis.
S.No. Systemic Manifestations No. of Patients %
1.
Bony abnormalities 
• Kyphoscoliosis
• Facial asymmetry 
• Local gigantism 
6 (8%)
2 (2.6%)
2 (2.6%)
2.
CNS Manifestations 
• Delayed milestones
• Learning difficulty
• Mental retardation
• Seizures 
2 (2.6%)
3 (4%)
2 (2.6%)
4 (5.3%)
3.
Ophthalmic Manifestations 
• Lisch  nodules 61 (81.3%)
Dermatological  examination:  Mollusca fibrosa was observed in 65 patients (86.6%). 
Plexiform neurofibromatosis was observed in 9 patients (12%). 
Pigmentary changes in the form of CALM occurred in 73 patients (97.3%) out of 
which  69  patients  had  more  than  6  in  number  (94.5%)  of  them,  34  cases  (46.5%) 
presenting after puberty showed bigger macules, more than 15mm. Freckling was noted 
in 86.6% of the case which was observed in the following pattern. 
• Palmar, Axillary and inguinal freckling – in 30 cases (45.9%) 
• Palmar, Axillary, inguinal and plantar freckling– in 6 cases (9.4%).
• Palmar and Axillary freckling  in 12 cases (18.4%)
• Palmar freckling only in 10 cases (15.3%)
• Axillary and inguinal freckling in 4 cases (6.1%)
• Axillary freckling only in 3 cases (4.6%)
One  female  patient  showed  extensive  facial  freckling,  one  patient  had  a  giant 
congenital melanocytic naevus over the trunk.
Localized hypertrichosis was observed in 3 cases (4%). Other skin lesions observed 
were prurigo nodularis,  Hansens disease,  and epidermal  naevus  2 cases respectively 
(2.6%)  syringoma,  macroglossia,  psoriasis,  one  case  respectively  (1.3%).  A  case  of 
sarcoma was seen. A case of pregnant female showed increased in size and number of 
lesions. 
Investigation : Electroencephalogram ( EEG ) was normal in all cases. ECG  was normal 
in  all  cases  expect  one  case  with  MS which  showed  Bifid‘P’  waves.  13  affordable 
patients underwent CT head and neck examination which were normal 12 patients. One 
patient with NF-II showed features suggestive of ependymoma, meningioma, Acoustic 
schwannoma which was confirmed with MRI.
Histopathological Examination showed unencapsulated tumour composing of pale 
eosin stained collagen with spindle shaped cells and eal shaped nuclei.  Few sections 
showed  sebaceous  gland  and  eccrine  gland  structures  within  the  tumour  mass. 
Extravasated RBC’s were also seen in some of the cases. One case showed tumour mass 
in close approximation with the epidermis.  
TUBEROUS  SCLEROSIS (TSC)
The total number of cases diagnosed to have tuberous sclerosis was 20 (18.3%) of 
whom 8 were males and 12 females. Age Distribution      (Table -3 ). The  age  of 
these patients ranged from 4 to 42 years – the mean age being 22 years.
TABLE – 3
The age and sex distribution in tuberous sclerosis complex (n=20)
Age No. of Case M F
0 – 10 yrs 3 1 2
11 – 20 yrs 8 3 5
21 – 30 yrs 5 3 2
31 – 40 yrs 2 1 1
41 – 50 yrs 2 - 2
TOTAL 20 8 12
Clinical  Presentation
The  patients  presented  with  seizures  14  cases,  (70%)  angiofibromas  20  cases 
(100%), 2 were  mentally retarded (10%).
H/o delayed mile stones was observed in 2 cases along with learning disabilities in 9 
( 45%) patients. 
Family History:   A positive family history was observed in 6  patients. The members 
affected in these 6 patients were mother 3, daughter in 2 and grandmother in one.  
General  Examination:  Was  normal  in  all  except  one  patient  who  had  moderate 
hypertension  (150/100 mmHg) on three consecutive reading on 3 days. 
Systemic examination : CNS – 2 patients were mentally retarded while IQ was found to 
be low in 5 cases (25%). Other systems were normal.
Ophthalmic examination :  was normal.
Skeletal examination : Showed bone cyst in one case. 
Dermotological examination: showed the following features. 
Angio  fibroma  was  observed  in  all  20  cases  (100%)  over  the  face.  Ash  leaf 
macule in 17 cases (85%). Of them 11 patients had a number of macules <3 and 6 
patients had >3 Shagreen patch occurred in 15 cases (75%) out of which 11 was in the 
lumbosacral, 2 in the upper back and 1 each in the thigh and gluteal region respectively. 
Molluscum  pendulum was seen in 7 cases (35%) , forehead plaque in 4 cases (20%), 
Koenen’s tumour in 6 cases (30%), CALM in 2 (10%), confetti in 2 (10%), gingival 
fibroma 1 (5%) and enamel pits in 12 (60%) cases. 
Investigation : Skiagram of skull was normal. CT Brain, showed sub-ependymal nodules 
in 5 patients, cortical tubers in 2 pts, astrocytoma in 1 and cyst in the parietal region in 
one patient was observed. 
Among the 10 CT investigated patients, 3 affordable patients underwent MRI which 
showed findings consistent with CT.
• USG  abdomen  was  done  in  all  patient  out  which  2  showed  renal 
angiomylipomas . ECG was normal in all cases.
• Histopathology of  angiofibroma showed few blood vessels  in  the mid dermis. 
Pale stained collagen in the upper dermis, fenestrated and deeply eosin strained 
collagen in the mid & deeper dermis. Histopathology of shagreen patch showed 
vertically oriented collagen in the mid & deeper dermis.
XERODERMA  PIGMENTOSUM   ( XP )
Out of the 109 cases who presented with neurocutaneous disorders, three 
cases (2.7%) had xeroderma pigmentosum among which one was female (21 years) and 
2 were males ( 17 & 32 years ).
Clinical Presentation 
Extensive freckling over the face, chest and arms which started around an average 
age of 6 years.  All had photophobia. The female patient had conjuctival congestion, 
pigmentation and loss of vision. One  patient had cheilitis. 
Family History  : The female patient had family history of XP, in her elder sister and a 
positive history of consanguity  in her parents. 
General examination :  2 patients were moderately built. One female patient was with 
short stature. 
Systemic examination:  revealed no abnormality including CNS assessment. 
Ophthalmic  examination:  showed conjunctival  pigmentation  and   congestion,   optic 
atrophy and loss of vision in the female patient.
Dermatological  examination:  revealed  extensive  freckles  and  lentigenes,  hyper  and 
hypo pigmentation over face, upper chest and arms mainly in the exposed surfaces. Mild 
xerosis was evident, but no telangiectasia could be made out. There was a fungating 
tumour over the cheek in one patient, which was biopsied and proved to be squamous 
cell carcinoma. The same patient showed mutilation of the nose which was found to be 
BCC.
Investigation :  Histopathological section of a hyperpigmented macule revealed heavily 
pigmented basal layer. Pigment deposits were also noted in the upper dermis. Patchy 
inflammatory cells in the upper dermis. Dilated blood vessels with RBC in the upper 
dermis, pale stained collagen in upper dermis and fenestrated in mid & lower dermis.
CT – Head & Neck of the female patient revealed bilateral maxillary and ethmoidal 
sinusitis, intraventricular obstructive hydrocephalus and diffuse cortical atrophy. 
STURGE – WEBER SYNDROME
1 patient (0.9%) was identified to have components of Sturge – Weber syndrome. 
Family History :  There was neither family history nor history of 
                             consanguinity.
Age & Sex incidence : One adolescent female patient was observed.
Clinical Features : She presented with portwine stain and epilepsy
General and  Systemic examination : Were normal
Ocular examination:   Conjuctival congestion, prominent blood vessels over the upper 
and lower eyelids were seen.
Dermatological examination :  Extensive portwine stain involving the forehead, upper 
and lower eye lids, conjunctiva, cheeks and chin was seen in both the patients.
Investigation : EEG showed focal epileptiform spikes in one patient.
NAEVUS  COMEDONICUS
1 female patient aged 23 (0.9%) presented with naevus comedonicus syndrome. 
Clinical Presentation :  the patient presented with clusters of closely set comedone like, 
firm,  slightly  elevated  papules  with  a  central  horny  plug,  which  are  unilaterally 
distributed in left side of the back. 
General, Systemic and  Ocular examination : Were normal.
Investigation : Were normal.
Histopathology showed deep and wide invagination of epidermis filled with keratin and 
concentric lamellae of collagen.
WAARDENBURG SYNDROME
2 patients out of 109 ( 1.8%) were identified as Waardenburg syndrome which 
consisted of mother in the age of 25 years and her 2 year old daughter. 
presenting Complaints :  Hearing loss, graying of hair and ocular discolouration were 
noted in both mother and child. 
Family history : No history of consagunity was noted 
General examination : Dystopia canthorum was noted.
Systemic examination :  Both patients  had defective hearing as bilateral sensoryneural 
deafness. No other CNS abnormality was detected. 
Ophthalamic examination : showed heterochromia of iris in both cases.
Dermatological examination : 
Mother:  Unilateral  heterochromia  of  iris,  white  forelock  and  congenital  vitiliginous 
patch over the thigh. Daughter: 2 years old girl child had bilateral heterochromia of iris. 
She had white forelock (poliosis), which was present since birth. 
Investigations:  Both patients showed changes in the audiogram. Both showed normal 
EEG, and all other investigatory parameters were normal.
EPIDERMAL  NAEVUS SYNDROME
2  female  cases  (  17&  26  yrs  )  out  of  109,  presented  as  epidermal  naevus 
syndrome.  They presented with seizures and verrucous asymptomatic lesions over the 
face and left flank in one and over one half of the body (Left) in the other. 
General and  Systemic examination: Were normal
Dermatological examination : Multiple closely set hyperpigmented verrucous  papules, 
some coalesced to form plaques arranged in a linear pattern over the one half of the 
body. 
Investigation :   EEG showed abnormal bilateral epileptiform spikes however CT was 
normal. 
GIANT CONGENITAL MELANOCYTIC NAEVUS
2  cases   (  one  female  child  and  one  adult  male  )  were  reported  with  giant 
congenital  melanocytic  naevus.  The  female  child  had  history  of  seizures  and 
hypertrichosis over the naevus was noticed.
General examination : was normal 
Dermatological examination :   The 1 ½ year old female child presented with a huge 
hyperpigmented patch occupying the trunk,  gluteal  region,  thighs and forearms,  few 
satellite lesions were seen over the face. Hypertrichosis over the patch was seen. 
The adult male had similar naevus over the chest and back.
Investigation :  EEG showed abnormal bilateral epileptiform spikes. 
ELEJALDE  SYNDROME
One male child ( 10 months ) presented as Elejalde syndrome. The presenting 
complaints were pigment dilution of the hair all over the body since birth, delayed mile 
stones & seizures for the past 2 months. The child was born of 2nd degree consanguinous 
marriage.
General examination : No head control. Other parameters were normal.
Systemic  examination  :  Cardiovascular  system,  respiratory  system,  per  abdomen  – 
normal.
CNS : Hypotonia and bilateral extensor plantar were noted 
Dermatological examination:  
Bronze skin, silvery hair over the scalp, eyebrows, eyelashes & body present. 
Investigations :  All were within normal limits except  hair shaft  examination showed 
coarse & irregular pigment clumps present.
OCULOCUTANEOUS  ALBINISM
One female patient out of 109 (0.9%) aged 32 years reported with Oculocutaneous 
Albinism.
Dermatological Examination : Showed total depigmentation of skin and hair. Face and 
both forearms showing actinic keratosis like lesions. 
Ocular  Examination : She had photophobia and nystagmus. 
ADAMS OLIVER SYNDROME
1 male child aged 1 year (0.9%) reported with Adams Oliver syndrome. 
CVS Examination:  Child had ventricular septal defect. 
Skeletal  Examination : Polydactyly was present. 
Dermatological Examination : Revealed two rounded, well circumscribed scalp lesions 
– aplasia cutis congenita – over the occiput and the parietal bone. Multiple skin tags and 
hypopigmented verrucous lesions were seen in the midline. 
Investigations : MRI brain suggestive of Dandy Walker malformation.
DISCUSSION
NEUROFIBROMATOSIS 
Neurocutaneous  disorders  are  genetically  determined  disorders   showing  both 
cutaneous  and  neurological  involvement.  The  cutaneous  markers  may  be  an  early 
diagnostic clue.
In this study, Neurofibromatosis (68.8%), topped the list followed by Tuberous 
sclerosis  complex  (18.3%),  and  other  rarer  disorders  like  Xeroderma  pigmentosum 
(2.7%), Giant congenital Melanocytic naevus (1.8%), Sturge Weber syndrome (0.9%), 
Waardenburg  syndrome  (1.8%),  Epidermal  neavus  syndrome  (1.8%),  Naevus 
comedonicus (0.9%) and Elejalde syndrome (0.9%), Oculocutaneous albinism (0.9%) 
Adams Oliver syndrome 0.9%.
Among the neurofibromatosis, NF1 was by far the most common and accounts for 
90.6% in this study which is consistent with the study reported by Husan SM et al79 
which showed a 90% incidence. The most frequent age group affected was 10-20 years. 
This age group coincides with puberty which time there is increase in number of lesion 
as noted by Friedmann JM Riccardi et al80. There is a male preponderance (56%) in this 
study as opposed to the studies of Jennifer R. Kam et al81 which indicates equal sex 
incidence. The most common clinical sign being CALM (97.3%) followed by mollusca 
fibrosa (86.6%). In a study by Neil Gold Berg et al82, the incidence of CALM was 69% 
CALM were the earliest marker to occur in concurrence with Crow and  Schull et all83, 84. 
Plexiform NF occurred in12% of cases in the study in contrast to 30% incidence in the 
study of Wolkenstein et al. 85 
Regarding pigmentary changes, axillary freckling occurred in 72% of cases which 
is consistent with 70% of axillary freckling by crowe FW et al86. Pruritus was noted in 
10.6%  as opposed to Riccardi VM et al87 report of 15 – 20% incidence. Incidence of 
seizure was 5.3% which was opposed with 10% incidence in study of cramer et al.88 
Lisch nodules has occurred in 81.3% of cases in contrast to           94– 97% of 
patients in the literature by Fliieler et al.89   Kyphoscoliosis was observed in 8% of cases 
as opposed ot 2% of case in the study of Riccardi VM et al.87  Learning difficulty was 
found in 4% case while the study of North Kn et al9  showed 30 – 70 % incidence. 
Incidence of NF type-V is 5.3% in the study by crowe FW et al5  it was considered 
to be a rare variant. Incidence of NF type VI is 2.6% in which both cases showed family 
history. One case of NF-II  has been reported in our study (1.3%) as opposed to the 10% 
incidence as per text.90
TUBEROUS  SCLEROSIS
Tuberous Sclerosis(18.3%) is the 2nd most common neurocutaneous disorder in 
this study. The common age group presented was 10 – 20 years with a mean age of 16 
years. This is consistent with the study of G. Raghu Rama Rao et al36  which showed 
mean age of 15.9 years. According to Rabindrnath Nambi et al91  there is an equal sex 
incidence, but this study showed a female preponderance. Family history was positive in 
30% in accordance with the study of H. North rupet et al92
The earliest clinical presentation was ash leaf macule which was present at birth 
as according to study of serguisz Jozwiak et al31. Ash leaf macule occurred in 85% as 
opposed to 80-100% incidence in the study of Jimbow K et al 32.
The commonest cutaneous manifestation was angiofibrona of the face which was 
seen in 100%. This is consistent with 96% incidence as per the studyof Gomez MR et 
al93 . Shagreen patch was observed in 75% as opposed to 50% reported by Harris stith et 
al94  . The Commonest site of the patch was lumbosacral region in consistent with the 
report of Tsao H et al.33 Molluscum pendulum were seen 35% of the cases as per the 
previous study. 
Forehead plaque was seen in 20% as opposed to 36% incidence in the study of 
webb et al.95 Koenens tumour was reported in 30% in contrast to 15% incidence in the 
study of Joswiak et al31. The prevalence of CALM was 10% as against the 30% reported 
by Tsoa H et al33. Seizures were reported in 70% cases as opposed to 53.33% incidence 
as per Anisya – Vasanth et al96. 10% case of mental retardation was seen in our study in 
contrast to 40% incidence in the study of Raghu Rama Rao et al.36
System Involvement :
CNS : Subependymal nodules were seen in 25% of cases as opposed to curatolo p 
et al97 study which revealed 50% incidence. 
Renal angiomyolipoma was detected in 10% in contrast to 60% reported in literature.
XERODERMA PIGMENTOSUM 
2.7% of study patients were involved. Male preponderance was noted, in contrast 
to equal sex incidence as per the study of  Neel JV et al.98 Photophobia and freckles were 
the common presentations. One female patient presented with squamous cell carcinoma 
of the cheek and basal cell carcinoma of the nose. This multiple malignant presentation 
is in accordance with the study of Mohanty P et al.99
STURGE – WEBER SYNDROME 
0.9% study patients were identified to have Sturge Weber syndrome with equal 
sex incidence. According to Tallman B et al,100 the usual cutaneous finding is a unilateral 
port  wine  stain.  Only  one  patient  presented  with  seizures,  in  contrast  to  reports  by 
Sujansky E et al101, where seizures occurred in 75 – 90%. The seizures were intractable 
to  medications  as  indicated  in  the  literature.  EEG  of  the  patient  showed  focal 
epileptiform spike discharges, which is very characteristic of Sturge Weber syndrome as 
per the study of Brennei RP et al102.
NAEVUS COMEDONICUS
0.9% of cases presented with Naevus comedonicus. The female patient presented 
with the lesion at the age of 16 yrs, in concurrence with records by Vasiloudes PE et 
al103. The site of comedone nevus in the study, was on the trunk as opposed to the study 
of Anderson NP et al104 in which face was the commonest site. 
WAARDENEBURG SYNDROME 
A rare  condition which constituted 1.8% of the study.  Both the patients  were 
females. Heterochromia iridis was present in 100% cases as opposed to 86% incidence 
in the literature. Incidence of deafness was 100% in contrast to 7-38%105 reported in 
literature.
EPIDERMAL NAEVUS SYNDROME 
1.8%  of  the  study  group  had  epidermal  naevus  syndrome.  Both  patients  had 
seizures  and  verrucous  epidermal  naevus,  which  was  consistent  with  the  study  of 
Gurecki PJ et al106. 
GIANT CONGENITAL MELANOCYTIC NAEVUS
It  was  observed  in  1.8% of  study  group.  Back  was  the  commonest  location. 
Hypertrichosis were seen in 100% of the cases. The above 2 finding were consistent 
with that of the literature107. One patient had an associated NF in accordance with the 
study of Zvulunova et al69. 
ELEJALDE SYNDROME 
1 case of Elejalde syndrome was reported in the study (0.9%). The male child had 
delayed mile stones, seizures, loss of head control, silvery hair and bronze skin. Hair 
shaft examination showed pigment clumnps. These findings were in accordance with the 
study of Afifi et al72.
OCULOCUTANEOUS  ALBINISM
Rare  condition which constituted  0.9% of  the  study.  The   female  had diffuse 
depigmentation of skin, hair and iris. She also had photophobia and nystagmus. 
ADAMS OLIVER SYNDROME 
0.9%  of  the  study  group  had  Adams  Oliver  Syndrome.  The  male  child  had 
polydactyly  and  ventricular  septal  defect.  He  had  aplasia  cutis  congenita  scalp  and 
keloid –like skin tags over the chest. MRI showed Dandy Walker malformation with 
obstructive hydrocephalus.
CONCLUSION
1. In the study of 109 cases of Neurocutaneous syndromes, Neurofibromatosis 
topped the list followed by Tuberous sclerosis complex.
2. NF – Type –I accounted for the maximum number of Neurofibromatosis.
3. The  most  common  clinical  sign  in  NF  was  CALM followed  by  mollusca 
fibrosa.
4. Axillary, inguinal, palmar and plantar freckling were the notable pigmentary 
changes in NF. 
5. Lisch nodules accounted for 81.3% of the cases in NF.
6. Skeletal abnormalities in the form of kyphoscoliosis, local gigantism and facial 
asymmetry were reported.
7. One case of sarcoma complicating NF was observed.
8. A case of NF-II with multiple intracranial tumours in MRI was detected. 
9. Tuberous  sclerosis  complex  is  the  second  most  common  neurocutaneous 
disorder.
10. Angiofibroma  was  observed  in  100%  cases  followed  by  ash  leaf  macules 
(85%).
11. Few patients had sub-ependymal nodules and cortical tubers.
12. One patient with astrocytoma and one patient with renal angiomyolipoma were 
observed.
13. Classical features of XP were observed in a patient who also had cutaneous 
malignancies – BCC over the nose and SCC  over the cheek.
14. Sturge – Weber syndrome with unilateral port wine stain with seizures was 
reported in our study.
15. One case of unilateral naevus comedonicus was reported.
16. Two cases of Waardenburg syndrome ( mother and child ) was observed in our 
study. Both had white forelock, heterochromia iridis and deafness.
17. Two cases  of  epidermal  naevus  syndrome with  extensive  involvement  and 
seizures were noted.
18. Two cases of giant congential melanocytic naevus were reported.
19. A case of Elejalde syndrome with typical clinical manifestations was observed. 
20. One case of oculocutaneous albinism was reported.
21. One case of Adams Oliver syndrome with Dandy Walker malformation has 
been reported. 
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